精优药业(00858.HK)发布公告,集团预期将取得亏损约介乎1.6亿港元与1.65亿港元之间,而对比截至2023年3月31日止年度为取得盈利。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.